Acasti Pharma develops innovative therapies for rare and orphan diseases, focusing on enhancing patient care with its robust pipeline.

Acasti Pharma (NASDAQ:ACST) is a biopharmaceutical company dedicated to improving the treatment of rare and orphan diseases. Traded under the symbol ACST on NASDAQ, the company focuses on developing and commercializing innovative pharmaceutical therapies. Acasti leverages its proprietary technologies to tackle medical challenges, with a robust pipeline of products in various stages of development. The company's objectives revolve around advancing its clinical programs, securing regulatory approvals, and exploring strategic partnerships. Acasti aims to make a significant impact in the realm of healthcare by providing effective solutions that address unmet medical needs and enhance the lives of patients worldwide.
GET YOUR GRAFA EDGE NOW
Sign up free to follow this company
We'll switch on a 30-day Edge trial as a welcome gift